rs148556640
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_206933.4(USH2A):āc.12608A>Gā(p.Gln4203Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00203 in 1,614,126 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.12608A>G | p.Gln4203Arg | missense_variant | 63/72 | ENST00000307340.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.12608A>G | p.Gln4203Arg | missense_variant | 63/72 | 1 | NM_206933.4 | P1 | |
USH2A | ENST00000674083.1 | c.12608A>G | p.Gln4203Arg | missense_variant | 63/73 |
Frequencies
GnomAD3 genomes AF: 0.00256 AC: 390AN: 152234Hom.: 9 Cov.: 32
GnomAD3 exomes AF: 0.00349 AC: 870AN: 249220Hom.: 10 AF XY: 0.00331 AC XY: 446AN XY: 134884
GnomAD4 exome AF: 0.00198 AC: 2889AN: 1461774Hom.: 46 Cov.: 37 AF XY: 0.00194 AC XY: 1408AN XY: 727176
GnomAD4 genome AF: 0.00256 AC: 390AN: 152352Hom.: 9 Cov.: 32 AF XY: 0.00384 AC XY: 286AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2019 | This variant is associated with the following publications: (PMID: 19737284, 21835308, 25133751) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | USH2A: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 12, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 11, 2012 | Gln4203Arg in exon 63 of USH2A: This variant is not expected to have clinical si gnificance because it is has been identified in 3.4% (6/178) of Asian chromosome s in a broad population by the 1000 Genomes Project. (http://www.ncbi.nlm.nih.go v/variation/tools/1000genomes/; dbSNP rs148556640). - |
Retinitis pigmentosa 39 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 04, 2023 | - - |
Usher syndrome type 2A Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 04, 2023 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at